Serology characteristics of SARS-CoV-2 infection after exposure and post-symptom onset
Top Cited Papers
Open Access
- 19 May 2020
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (2), 2000763
- https://doi.org/10.1183/13993003.00763-2020
Abstract
Background Timely diagnosis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a prerequisite for treatment and prevention. The serology characteristics and complement diagnosis value of the antibody test to RNA test need to be demonstrated. Method Serial sera of 80 patients with PCR-confirmed coronavirus disease 2019 (COVID-19) were collected at the First Affiliated Hospital of Zhejiang University, Hangzhou, China. Total antibody (Ab), IgM and IgG antibodies against SARS-CoV-2 were detected, and the antibody dynamics during the infection were described. Results The seroconversion rates for Ab, IgM and IgG were 98.8%, 93.8% and 93.8%, respectively. The first detectible serology marker was Ab, followed by IgM and IgG, with a median seroconversion time of 15, 18 and 20 days post exposure (d.p.e.) or 9, 10 and 12 days post onset (d.p.o.), respectively. The antibody levels increased rapidly beginning at 6 d.p.o. and were accompanied by a decline in viral load. For patients in the early stage of illness (0–7 d.p.o), Ab showed the highest sensitivity (64.1%) compared with IgM and IgG (33.3% for both; pConclusions A typical acute antibody response is induced during SARS-CoV-2 infection. Serology testing provides an important complement to RNA testing in the later stages of illness for pathogenic-specific diagnosis and helpful information to evaluate the adapted immunity status of patients.Funding Information
- China National Mega-Projects for Infectious Diseases (2017ZX10103008)
- the Science and Technology Major Project of Xiamen (3502Z2020YJ01)
This publication has 21 references indexed in Scilit:
- Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosisJournal of Medical Virology, 2020
- Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, HubeiPublished by Cold Spring Harbor Laboratory ,2020
- Comparison of throat swabs and sputum specimens for viral nucleic acid detection in 52 cases of novel coronavirus (SARS-Cov-2) infected pneumonia (COVID-19)Published by Cold Spring Harbor Laboratory ,2020
- Optimizing diagnostic strategy for novel coronavirus pneumonia, a multi-center study in Eastern ChinaPublished by Cold Spring Harbor Laboratory ,2020
- Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infectionsPublished by Cold Spring Harbor Laboratory ,2020
- Consistent Detection of 2019 Novel Coronavirus in SalivaClinical Infectious Diseases, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routesEmerging Microbes & Infections, 2020
- Longitudinal profile of antibodies against SARS‐coronavirus in SARS patients and their clinical significanceRespirology, 2006
- Longitudinal Profile of Immunoglobulin G (IgG), IgM, and IgA Antibodies against the Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in Patients with Pneumonia Due to the SARS CoronavirusClinical and Vaccine Immunology, 2004